Related Experiment Video
Updated: Mar 31, 2026
06:47
Echocardiography-guided Injection for Targeted and Reliable Intramyocardial Stem Cell Delivery in a Rat Model of Myocardial Infarction
Published on: July 25, 2025
693
Clinical experience with Angiojet: a comprehensive review
A M Ierardi1, G Xhepa, G Piffaretti
1Department of Radiology, Insubria University, Varese, Italy - gcarraf@gmail.com.
Summary
Rheolytic thrombectomy (RT) is increasingly used for percutaneous declotting. This review details the current status and applications of this minimally invasive vascular therapy.
Area of Science:
- Vascular Surgery
- Interventional Cardiology
- Endovascular Therapy
Background:
- Minimally invasive therapies have shifted vascular access management.
- Mechanical thrombectomy devices and physician experience have advanced declotting procedures.
- Percutaneous declotting utilizes thrombolysis, mechanical thrombectomy, or combined techniques.
Purpose of the Study:
- To review the current applications of percutaneous rheolytic thrombectomy.
- To highlight the increasing use of AngioJet™ rheolytic thrombectomy (RT).
Main Methods:
- Review of current literature on rheolytic thrombectomy.
- Analysis of AngioJet™ device usage in emergency and elective settings.
Main Results:
- Rheolytic thrombectomy (RT) is a growing technique in vascular declotting.
- The AngioJet™ system demonstrates increasing adoption for percutaneous procedures.
Conclusions:
- Percutaneous rheolytic thrombectomy is a significant advancement in vascular access management.
- RT offers a valuable option for various patient populations and clinical scenarios.
Related Concept Videos
01:26Angina IV: Management
425
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
425
01:26Cardiac Catheterization IV: Nursing Management
1.1K
Nursing responsibilities before cardiac catheterization include:Assess for allergies and establish baseline health status.Before cardiac catheterization, assess the patient for allergies to contrast dye. Perform a comprehensive baseline assessment, including vital signs, heart and breath sounds, and a neurovascular assessment of the extremities, noting distal pulses, skin color, and temperature. Instruct the patient to fast for 8-12 hours before the procedure. Evaluate baseline laboratory...
1.1K
01:28Cardiac Catheterization I: Pre-Procedure Overview
2.6K
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
2.6K
01:21Cardiac Catheterization II: Right Heart Catheterization
1.8K
Right Heart Catheterization: An OverviewRight heart catheterization is an invasive diagnostic procedure that measures right-sided cardiac and pulmonary artery pressures, calculates cardiac output, and identifies intracardiac shunts. It provides detailed hemodynamic data essential for diagnosing and managing various cardiovascular conditions, such as pulmonary hypertension.Access SitesCommon access sites for right heart catheterization include the internal jugular vein in the neck region, the...
1.8K
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
608
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
608
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
562
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
562